3-5
2026
影响因子区间
91天
平台估算
15%
2025
中国作者发文占比
580 SEK;65 USD;55 EUR
收费
期刊简介:ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.
【译文】ACS药理学与转化科学期刊发表高质量、创新性和有影响力的研究,涵盖生物科学的广泛领域,从基础和分子科学到转化前临床研究。考虑发表针对新型作用机制的临床研究,以及提供创新和方法论论文,以促进转化。我们优先考虑将基础药理学和/或生化发现与具有转化潜力的生理过程充分整合的研究。因此,采用体外和体内系统互补混合的研究对期刊特别感兴趣。尽管如此,所有具有明确转化相关性的创新和有影响力的研究都将被考虑。ACS药理学与转化科学期刊不发表关于未知浓度或未知化学成分的生物提取物的研究。鼓励作者使用预投稿咨询机制,以确保研究的相关性和适宜性。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |